Form 4: Clene Inc. Director Vallerie McLaughlin Granted Stock Options
SEC Form 4 Filing
Director Vallerie McLaughlin received stock options for 32,429 shares of Clene Inc. common stock on March 11, 2024.
Summary
- Vallerie McLaughlin, a director of Clene Inc., was granted stock options on March 11, 2024.
- The options are for 32,429 shares of Clene Inc. common stock.
- The exercise price is $0.44 per share.
- The options vest immediately upon grant and expire on March 11, 2034.
Sentiment
Score: 6
Explanation: The document is a routine disclosure of stock option grants, which is generally neutral. It indicates ongoing alignment of director interests with shareholders.
Positives
- The immediate vesting of the options could incentivize the director to work towards the company's success.
Industry Context
Stock options are a common form of executive compensation in the biotechnology industry, aligning the interests of management with those of shareholders.
Stakeholder Impact
- The stock option grant could potentially align the director's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 03/11/2024 | Date of the stock option grant. |
| 03/11/2034 | Expiration date of the stock options. |
| 03/12/2024 | Date of the signature on the form. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.